Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Non-Small-Cell Lung Cancer
 More »

  • Pharma Touting Phase II/III Wins in Run-Up to ASCO
    Boehringer Ingelheim will be presenting data from its Phase III studies on afatinib and nintedanib in two populations of patients with advanced non-small-cell-lung cancer (NSCLC) ...
    5-16-2013
  • FDA Approves Roche EGFR Mutation CDx for NSCLC
    it also approved for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) patients whose tumors show EFGR exon 19 deletions or exon 21 substitution mutations. ...
    5-15-2013
  • Softening the Blow from FOLFOX Treatment
    500,000 (about $79,000) Vinnova grant awarded last year, PledPharma has performed some preclinical studies on PledOx and chemotherapies involved with non-small-cell lung cancer. ...
    5-15-2013
  • Sorrento, Igdrasol Secure Exclusive E.U. Distribution Rights...
    Cynviloq is already approved and marketed in several countries for indications including metastatic breast cancer, non-small-cell lung cancer, and ovarian cancer. Sorrento and ...
    5-14-2013
  • Lilly Halts Development of Lymphoma Drug After Phase III Failure
    ... Gaynor said in the statement. Those two Phase III molecules are necitumumab, indicated for squamous non-small cell lung cancer; and ramucirumab for breast cancer, colorectal ...
    5-10-2013
  • Amgen Forms Joint Venture to Sell Vectibix in China
    Founded in 2003, Zhejiang launched Icotinib for non-small cell lung cancer (NSCLC) in China two years ago. Ownership of the new venture, to be named Amgen-Beta Pharmaceuticals, ...
    5-10-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Gene via FISH in FFPE non-small cell lung cancer (NSCLC) tissue specimens to aid in identifying patients eligible for treatment with Xalkori (crizotinib). For prescription use ...
    5-9-2013
  • Cancer Diagnostics, Pushing the Boundaries
    ... in the OncoNetwork Consortium, evaluated a custom gene panel that targets hotspot mutations in 22 genes implicated in colorectal cancer and non-small-cell lung carcinoma. ...
    5-8-2013
  • Life Technologies: A Look Back
    On July 25, 2012, Life Technologies acquired Pinpoint Genomics and its early-stage non-small-cell lung cancer test. In October Life Technologies acquired Compendia Bioscience, a ...
    4-15-2013
  • Women and Smoking
    proportion of men abandon the habit, lung cancer has become the leading cause of cancer ... receptors might modulate the growth of non-small cell lung cancer (NSCLC) cells. ...
    4-3-2013
  • Personalized Medicine: Health Economic Aspects
    ... The introduction of a companion diagnostic strategy in advanced non-small cell lung cancer reduced overall treatment costs by more than € 800 compared to current treatment. 5 A ...
    4-2-2013
  • Exploiting Folate Pathways to Treat Cancer
    ... A Phase III trial of vintafolide in platinum-resistant ovarian cancer is under way, as well as a Phase II/III trial of vintafolide in non-small-cell lung cancer. The folate ...
    4-1-2013
  • Non-Small-Cell Lung Cancer
    Among the many "living medical textbooks" is the one I highlight here as an example: the textbook for non-small-cell lung cancer (NSCLC). The topic of this "living textbook" ...
    4-1-2013
  • ArQule Regains Rights to AKT Inhibitor from Daiichi Sankyo
    And in October, ARQ 197 delivered improvement in progression-free survival, but not overall survival, in a Phase III trial in patients with non-small cell lung cancer. In addition ...
    4-1-2013
  • Personalized Medicine: Translation of Concepts
    ... For example, if we want to test a medicine like gefitinib, we do not need patients who are clinically diagnosed with non-small cell lung cancer, but patients with a specific EGFR ...
    3-19-2013
  • More »

    Journal Articles

  • Exhaled Matrix Metalloproteinase-9 in Lung Cancer
    Silvio Orlando, Maria P. Foschino-Barbaro, Giovanna E. Carpagnano, Grazia P Palladino, Domenico Martinelli, Donato Lacedonia, maria pia foschino barbaro
    Rejuvenation Research
    Exhaled Matrix Metalloproteinase-9 in Lung Cancer Rejuvenation Research Abstract Background: ... described in the serum and airways of non-small cell lung cancer (NSCLC) patients. ...
  • Targeted Therapy at the End of Life for Patients with Lung Cancer
    Alvin S. Wong, Catherine Teo, Siew-Woon Lim, Eunice Wong, Ross A. Soo, Noreen Chan
    Journal of Palliative Medicine
    Targeted Therapy at the End of Life for Patients with Lung Cancer Journal of Palliative ... end of life in non-small cell lung cancer (NSCLC) patients who died in our institution. ...
  • Preferences of Patients with Advanced Lung Cancer Regarding the...
    Koen Pardon, Reginald Deschepper, Robert Vander Stichele, Jan L. Bernheim, Freddy Mortier, Nathalie Bossuyt, Denis Schallier, Paul Germonpré, Daniella Galdermans, Willem Van Kerckhoven, Luc Deliens
    Journal of Palliative Medicine
    Preferences of Patients with Advanced Lung Cancer Regarding the Involvement of Family and ... recruited patients with initial non-small-cell lung cancer, stage IIIb or IV. The ...
  • Components of Early Outpatient Palliative Care Consultation in...
    Juliet Jacobsen, Vicki Jackson, Constance Dahlin, Joseph Greer, Pedro Perez-Cruz, J. Andrew Billings, William Pirl, Jennifer Temel
    Journal of Palliative Medicine
    Patients with Metastatic Nonsmall Cell Lung Cancer Journal of Palliative Medicine Abstract ... with newly diagnosed metastatic non-small cell lung cancer (NSCLC), we analyzed ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll